Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
soy isoflavones
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Role of Soy Supplementation in Prostate Cancer Development
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
CLIN-006-05S
, NCT00255125
2.
Phase III Randomized Study of Soy Protein/Isoflavones and Venlafaxine on Vasomotor Symptoms in Patients With Prostate Cancer Undergoing Hormonal Manipulation
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
21 and over
Sponsor:
NCI
Protocol IDs:
CCCWFU-97405
, CCCWFU 97405, CCCWFU-BG05-529, NCT00354432
3.
A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy
Phase:
Phase II, Phase I
Type:
Supportive care
Status:
Active
Age:
20 to 70
Sponsor:
Other
Protocol IDs:
DOH96-TD-I-111-003
, NCT00555516
4.
Soy Isoflavones and Breast Cancer Risk Reduction
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
30 to 42
Sponsor:
NCI, Other
Protocol IDs:
03-260
, UTMB GCRC #635, NIH R01-CA95545, NIH NCRR GCRC M01 RR00073, NCT00204490
5.
Phase II Study of Cholecalciferol and Soy Supplementation in Patients With Biochemically Recurrent Prostate Cancer Following Failed Definitive Local Therapy
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
CCCWFU-85106
, CCCWFU-IRB00000371, CCCWFU 85106, NCT00499408
6.
Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy
Phase:
Phase II
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
9639
, NCT00594620
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute